Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to 0.09.

  • Dare Bioscience's Equity Ratio rose 21306.71% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year increase of 21306.71%. This contributed to the annual value of 0.27 for FY2024, which is 1469.36% down from last year.
  • As of Q3 2025, Dare Bioscience's Equity Ratio stood at 0.09, which was up 21306.71% from 0.98 recorded in Q2 2025.
  • Dare Bioscience's Equity Ratio's 5-year high stood at 0.69 during Q4 2021, with a 5-year trough of 0.98 in Q2 2025.
  • Moreover, its 5-year median value for Equity Ratio was 0.11 (2024), whereas its average is 0.08.
  • In the last 5 years, Dare Bioscience's Equity Ratio soared by 133856.66% in 2021 and then tumbled by 96686.5% in 2025.
  • Dare Bioscience's Equity Ratio (Quarter) stood at 0.69 in 2021, then crashed by 63.49% to 0.25 in 2022, then tumbled by 193.54% to 0.24 in 2023, then dropped by 14.69% to 0.27 in 2024, then surged by 134.17% to 0.09 in 2025.
  • Its Equity Ratio was 0.09 in Q3 2025, compared to 0.98 in Q2 2025 and 0.51 in Q1 2025.